Ursula Berger

Increased expression of matrix metalloproteinases (MMP)-2, MMP-9, and the urokinase-type plasminogen activator is associated with progression from benign to advanced ovarian cancer.

Barbara Schmalfeldt, Dieter Prechtel, Kathrin Härting et al. · PubMed · 2001 · 336 citations

Protease Inhibitors, Tumoral Pathology, Oncology +14

Y‐box factor YB‐1 predicts drug resistance and patient outcome in breast cancer independent of clinically relevant tumor biologic factors HER2, uPA and PAI‐1

Martin Janz, Nadia Harbeck, P. Dettmar et al. · International Journal of Cancer · 2001 · 182 citations · Full text

Early reduction of BCR-ABL mRNA transcript levels predicts cytogenetic response in chronic phase CML patients treated with imatinib after failure of interferon α

Kirsten Merx, M. C. Muller, Sebastian Kreil et al. · Leukemia · 2002 · 171 citations

Hematological Malignancy, Chromatin Structure, Epigenetic Regulation +11

Methylohalobius crimeensis gen. nov., sp. nov., a moderately halophilic, methanotrophic bacterium isolated from hypersaline lakes of Crimea

Jürgen Heyer, Ursula Berger, Martin Hardt et al. · INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY · 2005 · 133 citations

Prognostic significance of urokinase (uPA) and its inhibitor PAI-1 for survival in advanced ovarian carcinoma stage FIGO IIIc

W. Kühn, Barbara Schmalfeldt, Ute Reuning et al. · British Journal of Cancer · 1999 · 130 citations · Full text